Tales From The Road
Angus McQuilken, VP of Business Development & Public Affairs, LaVoieHealthScience
Angus McQuilken serves as Vice President for Business Development and Public Affairs for LaVoieHealthScience, a Boston-based firm that provides strategic communications programs integrating public and investor relations, marketing and communications. From 2008-2017 McQuilken served as Vice President for Communications & Marketing for the Massachusetts Life Sciences Center, the agency charged with implementing Massachusetts’ ten-year, $1 billion Life Sciences Initiative, where he served as part of the start-up and executive management teams. From 2004-2008 he focused on health care communications and advocacy while serving as Vice President for Public Affairs for Planned Parenthood League of Massachusetts. McQuilken has also served as Chief of Staff for Massachusetts State Senator Cheryl Jacques, and as Deputy Communications Director for the Democratic National Convention Committee. McQuilken is an adjunct faculty member at Lasell College, where he teaches courses focused on both public relations and public speaking.
Magda Marquet, Chairman & Co-Founder, AltheaDx
Magda Marquet is the Chairman and co-Founder of Althea, an Ajinomoto company. Dr. Marquet is also co-founder of Althea Dx, a precision medicine company. Dr. Marquet has three decades of experience in the biotechnology industry in the US and Europe. She is also co-founder and co-CEO of Alma Life Sciences, an investment and consulting firm with a portfolio of over twenty companies. Prior to starting Althea, she held management positions at Vical Inc., Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene. She currently serves as a Board member for Sente, Independa and Portable Genomics. She is also co-Chairman of the Advisory Board of MD Revolution. Dr. Marquet was Chairman of BIOCOM (2013-2014) and is Chair of the Board of Visitors of the UCSD Moores Cancer Center. She serves as a Director of the Economic Development Corporation (EDC- Executive Committee) and of the Kyoto Symposium Organization. She is also a member of the UCSD Biological Sciences Dean Leadership Council and an advisor for the Chopra Foundation. Dr. Marquet holds a Ph.D in Biochemical Engineering from INSA/University of Toulouse, France. Dr. Marquet has received numerous awards throughout her career including the 2005 Regional Ernst&Young Entrepreneur of the Year Award in the Life Sciences category, the Athena Pinnacle Award and the Exemplary Service Award from the San Diego Business Journal. She is the first woman inducted in the Connect Entrepreneur Hall of Fame (2016) and the Director of the Year Award recipient (2016-Corporate Governance) from the Corporate Directors Forum.
Michael Tippie, CEO, Lipidomics
Michael Tippie is the CEO of Lipidomics, Inc, focused on cosmetic solutions and pharmaceutical treatments for eczema. Michael has previously been a life science venture capitalist (Norwest Venture Partners, Medical Innovation Partners, Milk Street Ventures, ONAMI), a senior executive in early stage life science companies (TomegaVax, CNS Response, Avior Therapeutics, LifeSpan BioSciences, StressGen Biotechnologies, Tacora) and a research chemist in the pharmaceutical and diagnostics industry (Syntex and Syva Research). Michael has done strategic alliances with many pharma companies, as well as raising over $300 MM in equity capital, including two IPOs to date. Michael holds an MBA from the Sloan School of Management at MIT, an MS in Chemistry from the University of Washington (with additional graduate work in Immunology, Proteomics and Genomics) as well as a BA in Chemistry from Reed College.
Mike Moradi, Co-Founder & CEO, Sensulin
Mr. Moradi is a successful entrepreneur, having founded or been a principal in several biopharma and nanotech startups. His current company Sensulin is developing a next-generation insulin for diabetes. Previously, Mike was a co-founder and CEO of an ocular pharmaceutical company and specialty Contract Research Organization (eyeCRO), which was #264 fastest growing private company in the 2009 Inc. 500. He co-founded Nanopolaris (now Unidym), which was acquired in 2011 by a publicly traded South Korean company for $145M USD, and NanoSource, which was acquired by DuPont in 2002, largely considered the first major acquisition in the nanotech space.
Joyce Lonergan, Founder & CEO, Mellitus
Joyce Lonergan has over 25 years of experience in industry, venture capital and Wall Street with emerging healthcare companies. Ms. Lonergan previously served as a Managing Partner at SR One. Prior to that, Ms. Lonergan co-founded and served as Managing Director of Caxton Healthcare Venture Management, LLC. She previously served as Vice President of Corporate Development and Corporate Communications and Investor Relations at Chiron Corporation. Earlier in her career, Ms. Lonergan was a Biotechnology Equity Research Analyst at Cowen and Company. She also had previous investment and business development roles at Vector Fund Management and Repligen Corporation. Ms. Lonergan began her career in research at Tufts Medical Center. Ms. Lonergan holds a B.S. in biology from Emmanuel College and an MBA from the Simmons College Graduate School of Management.